<code id='C0337E2044'></code><style id='C0337E2044'></style>
    • <acronym id='C0337E2044'></acronym>
      <center id='C0337E2044'><center id='C0337E2044'><tfoot id='C0337E2044'></tfoot></center><abbr id='C0337E2044'><dir id='C0337E2044'><tfoot id='C0337E2044'></tfoot><noframes id='C0337E2044'>

    • <optgroup id='C0337E2044'><strike id='C0337E2044'><sup id='C0337E2044'></sup></strike><code id='C0337E2044'></code></optgroup>
        1. <b id='C0337E2044'><label id='C0337E2044'><select id='C0337E2044'><dt id='C0337E2044'><span id='C0337E2044'></span></dt></select></label></b><u id='C0337E2044'></u>
          <i id='C0337E2044'><strike id='C0337E2044'><tt id='C0337E2044'><pre id='C0337E2044'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:knowledge    Page View:28739
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In